CorMedix Inc. (CRMD) Stock Forecast
Data as of Jun 17, 2026Healthcare · Current price $8.64 (+0.58%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 6, 2026 | Roanna Ruiz | Leerink Partners | $13.00 | +50.5% |
| Oct 21, 2025 | Gregory Renza | RBC Capital | $22.00 | +154.6% |
| Aug 8, 2025 | Brandon Folkes | H.C. Wainwright | $17.00 | +96.8% |
| Mar 13, 2024 | Gregory Renza | RBC Capital | $9.00 | +4.2% |
Top Analysts Covering CRMD
CRMD vs Sector & Market
| Metric | CRMD | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.40 |
| Analyst Count | 12 | 8 | 19 |
| Target Upside | +59.0% | +11475.0% | +17.1% |
| P/E Ratio | 4.09 | 3.91 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $303M | $308M | $314M | 5 |
| 2027-03-31 | $67M | $72M | $79M | 3 |
| 2027-06-30 | $68M | $74M | $81M | 2 |
| 2027-09-30 | $68M | $74M | $81M | 2 |
| 2027-12-31 | $70M | $76M | $84M | 3 |
| 2028-03-31 | $84M | $91M | $100M | 2 |
| 2028-06-30 | $88M | $95M | $104M | 1 |
| 2028-09-30 | $88M | $95M | $104M | 1 |
| 2028-12-31 | $91M | $99M | $109M | 2 |
| 2029-12-31 | $406M | $425M | $446M | 2 |
| 2030-12-31 | $536M | $560M | $589M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.42 | $0.66 | $1.02 | 4 |
| 2027-03-31 | $0.16 | $0.18 | $0.21 | 1 |
| 2027-06-30 | $0.16 | $0.18 | $0.21 | 1 |
| 2027-09-30 | $0.15 | $0.17 | $0.19 | 1 |
| 2027-12-31 | $0.16 | $0.18 | $0.20 | 1 |
| 2028-03-31 | $0.33 | $0.36 | $0.41 | 1 |
| 2028-06-30 | $0.34 | $0.37 | $0.42 | 1 |
| 2028-09-30 | $0.33 | $0.37 | $0.42 | 1 |
| 2028-12-31 | $0.34 | $0.38 | $0.43 | 1 |
| 2029-12-31 | $1.14 | $1.21 | $1.29 | 1 |
| 2030-12-31 | $1.74 | $1.85 | $1.97 | 1 |
Frequently Asked Questions
What is the analyst consensus for CRMD?
The consensus among 12 analysts covering CorMedix Inc. (CRMD) is Buy with an average price target of $14.00.
What is the highest price target for CRMD?
The highest price target for CRMD is $22.00, set by Gregory Renza at RBC Capital on 2025-10-21.
What is the lowest price target for CRMD?
The lowest price target for CRMD is $9.00, set by Gregory Renza at RBC Capital on 2024-03-13.
How many analysts cover CRMD?
12 analysts have issued ratings for CorMedix Inc. in the past 12 months.
Is CRMD a buy or sell right now?
Based on 12 analyst ratings, CRMD has a consensus rating of Buy (2.00/5) with a +59.0% upside to the consensus target of $14.00.
What are the earnings estimates for CRMD?
Analysts estimate CRMD will report EPS of $0.66 for the period ending 2026-12-31, with revenue estimated at $308M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.